Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating substantial results in the management of type 2 diabetes. This artificial peptide mimics the actions of naturally occurring GLP-1, a https://fatallisto.com/story10852765/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes